GlassScriptPhysician profile
Blake A Weidaw
NPI 1467471607
$1,645.40
in general payments reported to CMS, 2019-2025
9 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.33 · 2021: $13.10 · 2022: $13.53 · 2023: $111 · 2024: $1,114 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810 · Travel and Lodging: $780 · Education: $15.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $809.54 |
| Travel and Lodging | $780.24 |
| Education | $15.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $821.98 | 2024 | Gelpoint V-Path |
| Shield Therapeutics INC | $238.38 | 2024-2025 | |
| Astellas Pharma US INC | $176.47 | 2024-2025 | Veozah |
| Biogen, INC. | $143.50 | 2025 | Zurzuvae |
| Myriad Women'S Health, INC. | $75.42 | 2023 | Myrisk |
| Millicent US INC | $61.63 | 2023-2024 | Intrarosa |
| Hologic Sales and Service, LLC | $59.18 | 2021-2025 | Aptima |
| Exact Sciences Corporation | $41.98 | 2023-2024 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $26.86 | 2019-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Weidaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.